Bill Gates's WST Position Overview
Bill Gates (via Gates Foundation Trust) currently holds 444,500 shares of West Pharmaceutical Services, Inc. (WST) worth $116.61 M, representing 0.32% of the portfolio. First purchased in 2025-Q1, this short-term holding has been held for 3 quarters.
Based on 13F filings, Bill Gates has maintained this position in WST for several quarters, showing initial confidence in the investment.
Analysis based on 13F filings available since 2013 Q2
Bill Gates's West Pharmaceutical Services (WST) Holding Value Over Time
Track share changes against reported price movement
Quarterly West Pharmaceutical Services (WST) Trades by Bill Gates
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2025 | +444,500 | New Buy | 444,500 | $223.88 |
Bill Gates's West Pharmaceutical Services Investment FAQs
Bill Gates first purchased West Pharmaceutical Services, Inc. (WST) in Q1 2025, acquiring 444,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Bill Gates has held West Pharmaceutical Services, Inc. (WST) for 3 quarters since Q1 2025.
Bill Gates's largest addition to West Pharmaceutical Services, Inc. (WST) was in Q1 2025, adding 444,500 shares worth $99.51 M.
According to the latest 13F filing for Q3 2025, Bill Gates's firm, Gates Foundation Trust, owns 444,500 shares of West Pharmaceutical Services, Inc. (WST), valued at approximately $116.61 M.
As of the Q3 2025 filing, West Pharmaceutical Services, Inc. (WST) represents approximately 0.32% of Bill Gates's publicly disclosed stock portfolio, making it one of their key holdings.
Bill Gates's peak holding in West Pharmaceutical Services, Inc. (WST) was 444,500 shares, as reported at the end of Q1 2025.